Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBT-9 in Healthy Volunteers and CKD Stage 3/4
NCT04072861Phase 1Completed
- Sponsor
- Renibus Therapeutics
- Start
- Mar 2019
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of tin protoporphyrin IX in chronic kidney disease (CKD) (3 cohorts), sponsored by Renibus Therapeutics. Primary endpoints: Plasma Ferritin Levels, Plasma Heme Oxygenase-1 Levels and 1 more. Started Mar 2019; status: completed.
02
Drugs
tin protoporphyrin IX
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT04072861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04072861.